Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 29Paclitaxel 7Magnetic Resonance Spectroscopy 7Cisplatin 7Pemetrexed 6Docetaxel 6Carboplatin 6Standard of Care 5Radiotherapy 5Nivolumab 5Drug Therapy 5Specimen Handling 4Gemcitabine 4Cetuximab 4Blood Specimen Collection 4epacadostat 3X-Rays 3Surveys and Questionnaires 3Practice Guidelines as Topic 3Oncolytic Virotherapy 3Nicotine 3Fluorouracil 3Filgrastim 3Cyclophosphamide 3Bupropion 3Bortezomib 3Biopsy 3spartalizumab 2selpercatinib 2sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Lutetium × Head & Neck × Clear all
NCT07274852 2026-01-06

A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 1 Recruiting
22 enrolled
BreastHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡